Depletion of CD25(+) T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma

Ítems similars

• Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
  per: Jing, Weiqing, et al.
  Publicat: (2009)
• Expression of Macrophage Migration Inhibitory Factor (MIF) by Neuroblastoma Leads to the Inhibition of Anti-Tumor T Cell Reactivity In Vivo()
  per: Zhou, Qiang, et al.
  Publicat: (2008)
• Induction of a VLA-2 (CD49b)-Expressing Effector T Cell Population by a Cell-Based Neuroblastoma Vaccine Expressing CD137L
  per: Yan, Xiaocai, et al.
  Publicat: (2008)
• Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo
  per: Yan, Xiaocai, et al.
  Publicat: (2004)
• Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine
  per: Jing, Weiqing, et al.
  Publicat: (2007)